Vimarsana
Biggest News Aggregation in the World

Page 22 - Point Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Point Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Point Partners Today - Breaking & Trending Today

Short Interest in Evolus, Inc. (NASDAQ:EOLS) Expands By 7.9% - Vimarsana News

Short Interest in Evolus, Inc. (NASDAQ:EOLS) Expands By 7.9%

Evolus, Inc. (NASDAQ:EOLS – Get Free Report) was the recipient of a large growth in short interest in September. As of September 30th, there was short interest totalling 3,840,000 shares, a growth of 7.9% from the September 15th total of 3,560,000 shares. Based on an average trading volume of 542,100 shares, the short-interest ratio is […]

Amicus Therapeutics (NASDAQ:FOLD) PT Lowered to $14.00 - Vimarsana News

Amicus Therapeutics (NASDAQ:FOLD) PT Lowered to $14.00

Amicus Therapeutics (NASDAQ:FOLD – Free Report) had its target price lowered by Morgan Stanley from $15.00 to $14.00 in a research note issued to investors on Tuesday, Benzinga reports. Morgan Stanley currently has an equal weight rating on the biopharmaceutical company’s stock. FOLD has been the subject of a number of other reports. Bank of […]

Moody Aldrich Partners LLC Buys Shares of 145,442 POINT Biopharma Global Inc. (NASDAQ:PNT) - Vimarsana News

Moody Aldrich Partners LLC Buys Shares of 145,442 POINT Biopharma Global Inc. (NASDAQ:PNT)

Moody Aldrich Partners LLC bought a new stake in POINT Biopharma Global Inc. (NASDAQ:PNT – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 145,442 shares of the company’s stock, valued at approximately $1,318,000. A number of other hedge […]

Reneo Pharmaceuticals (NASDAQ:RPHM) Receives Buy Rating from HC Wainwright - Vimarsana News

Reneo Pharmaceuticals (NASDAQ:RPHM) Receives Buy Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $30.00 price objective on the stock. Separately, Bank of America assumed coverage on shares of Reneo Pharmaceuticals in a research note on Monday, July 3rd. They issued […]

POINT Biopharma Global (NASDAQ:PNT) Hits New 52-Week High at $12.68 - Vimarsana News

POINT Biopharma Global (NASDAQ:PNT) Hits New 52-Week High at $12.68

POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report) reached a new 52-week high on Friday . The stock traded as high as $12.68 and last traded at $12.65, with a volume of 957816 shares traded. The stock had previously closed at $12.36. Wall Street Analyst Weigh In A number of brokerages have weighed in […]

Source: wkrb13.com